Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of July 26)
This week's View covers articles about the association of low-level alcohol consumption and incident atrial fibrillation in middle-aged adults and the effectiveness of Pfizer-BioNTech and AstraZeneca vaccines against symptomatic disease caused by the severe acute respiratory syndrome coronavirus 2 delta variant and offers key points from an ACC Expert Consensus Decision Pathway on the management of atherosclerotic cardiovascular disease risk reduction in patients with persistent hypertriglyceridemia.
Clinical Topics: Arrhythmias and Clinical EP, Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Dyslipidemia, Prevention, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Homozygous Familial Hypercholesterolemia, Hypertriglyceridemia, Lipid Metabolism, Nonstatins, Novel Agents, Primary Hyperlipidemia, Statins, Diet, Exercise
Keywords: EaglesEyeView, Alcoholic Beverages, Alcohol Drinking, Arrhythmias, Cardiac, Atherosclerosis, Atrial Fibrillation, Beer, Binge Drinking, Blood Glucose, Cholesterol, HDL, Cholesterol, LDL, Coronavirus, Coronavirus Infections, COVID-19, ACC COVID-19 Podcast, Diabetes Mellitus, Type 2, Diet, Drug Therapy, Dyslipidemias, Ethanol, Exercise, Fatty Acids, Fatty Acids, Omega-3, Fenofibrate, Fibric Acids, Health Policy, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypercholesterolemia, Hyperlipoproteinemia Type I, Incidence, Life Style, Lipids, Lipoproteins, Metabolic Syndrome, Myocardial Infarction, Pancreatitis, Polymerase Chain Reaction, Primary Prevention, Risk, Risk Reduction Behavior, Risk Factors, SARS-CoV-2, Secondary Prevention, Stroke, Therapeutics, Treatment Outcome, Triglycerides, Vaccination, Vaccines, Vascular Diseases, Wine
< Back to Listings